5
Note: The Association may modify the format to fit the look and feel of the media on which it is
displayed or distributed.
Abstract Selection Process
All abstracts successfully submitted are peer-reviewed through a blind review process.
Originality of work, adequacy of data, and clarity of exposition are the determinants in the selection of
abstracts. An abstract that does not present the results of the study will not be accepted.
The final decision with respect to selection, programming, and/or publication of any abstract will be
made by the Association's Scientific Sessions Meeting Planning Committee.
Abstracts may be selected for oral presentation, poster presentation, published only, or not selected.
Abstracts selected for oral presentation, poster presentation, and published only will be published on
the journal Diabetes® website. Abstracts selected as Published Only will not be presented at the 84
th
Scientific Sessions.
Abstract acceptance status will be sent via email to the designated presenting author in early-March.
Make sure their email settings will allow correspondence from abstracts@diabetes.org.
Embargo Policy
All meeting attendees, members of the media, companies, institutions, organizations, universities,
investment advisors, and all other individuals are required to abide by the embargo policy governing the
American Diabetes Association’s (ADA’s) 84
th
Scientific Sessions.
An embargo means that information from any abstract or presentation is confidential and may not be
announced, publicized, or distributed before the embargo date and time. This policy applies to all
formats of release, including the Scientific Sessions online itinerary planner, meeting app, Abstracts on
USB, abstracts published on the journal Diabetes® website, and any other distribution method.
The purpose of the embargo policy is to protect the scientific integrity of the abstract submissions
presented at the ADA’s Scientific Sessions. All submissions are to be considered preliminary until the
time of presentation or authorized for public release. Violation of the embargo policy by release of
information contained in any abstract prior to its embargoed date and time will result in the individual,
as well as the employer/affiliated company, institution, organization, etc., being removed from ADA’s
84
th
Scientific Sessions, with a two-year ban on returning.
Prior Publication:
If the abstract is also submitted as a manuscript for publication, authors are responsible for coordinating
a publication date that abides by the Association’s embargo policy. If publication occurs online or in
print before the specific embargo date and time set by the Association, the abstract must be withdrawn.
Please notify the Association via email at abstracts@diabetes.org. Failure to notify the Association of
publication will result in a moratorium on the submission of abstracts for all authors in question for two
years.